医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2012年
29期
126-127
,共2页
围手术期%糖尿病,2 型%胰岛素输注系统
圍手術期%糖尿病,2 型%胰島素輸註繫統
위수술기%당뇨병,2 형%이도소수주계통
Peri-operation%Diabetes melitus Type 2%Insulin infusion systems
目的比较胰岛素泵持续皮下输注胰岛素(continuous subcutaneous insulin infusion,CSI)及多次皮下注射胰岛素(multiple subcutaneous insulin injection,MSI)对控制围手术期糖尿病患者血糖水平、安全性等疗效观察.方法2010年9月至2012年9月,我院102例糖尿病围手术期患者,随机分组,分别应用胰岛素泵和常规皮下注射胰岛素控制血糖,观察血糖水平、胰岛素用量、低血糖发生率、切口愈合等级等指标,比较两组之间的差别.结果 CSII 组(A 组)达到理想血糖所需时间少于 MSI 组(B 组),所需胰岛素用量及低血糖发生率也低于 B 组.切口愈合等级两组无统计学意义.结论对择期手术患者胰岛素泵治疗能缩短术前待手术期,血糖达标时间减少,使患者血糖得到理想控制,减少低血糖发生,是控制围手术期血糖的有效办法.
目的比較胰島素泵持續皮下輸註胰島素(continuous subcutaneous insulin infusion,CSI)及多次皮下註射胰島素(multiple subcutaneous insulin injection,MSI)對控製圍手術期糖尿病患者血糖水平、安全性等療效觀察.方法2010年9月至2012年9月,我院102例糖尿病圍手術期患者,隨機分組,分彆應用胰島素泵和常規皮下註射胰島素控製血糖,觀察血糖水平、胰島素用量、低血糖髮生率、切口愈閤等級等指標,比較兩組之間的差彆.結果 CSII 組(A 組)達到理想血糖所需時間少于 MSI 組(B 組),所需胰島素用量及低血糖髮生率也低于 B 組.切口愈閤等級兩組無統計學意義.結論對擇期手術患者胰島素泵治療能縮短術前待手術期,血糖達標時間減少,使患者血糖得到理想控製,減少低血糖髮生,是控製圍手術期血糖的有效辦法.
목적비교이도소빙지속피하수주이도소(continuous subcutaneous insulin infusion,CSI)급다차피하주사이도소(multiple subcutaneous insulin injection,MSI)대공제위수술기당뇨병환자혈당수평、안전성등료효관찰.방법2010년9월지2012년9월,아원102례당뇨병위수술기환자,수궤분조,분별응용이도소빙화상규피하주사이도소공제혈당,관찰혈당수평、이도소용량、저혈당발생솔、절구유합등급등지표,비교량조지간적차별.결과 CSII 조(A 조)체도이상혈당소수시간소우 MSI 조(B 조),소수이도소용량급저혈당발생솔야저우 B 조.절구유합등급량조무통계학의의.결론대택기수술환자이도소빙치료능축단술전대수술기,혈당체표시간감소,사환자혈당득도이상공제,감소저혈당발생,시공제위수술기혈당적유효판법.
Objective To assess the clinical therapeutic effect of the CSI(continuous subcutaneous insulin infusion) and the MSI(multiple subcutaneous insulin injection) to the perioperative diabetic patients. Methods From Sept. 2010 to Sept. 2012, 102 perioperative diabetic patients were randomly divided into the CSI group and the MSI group. After the treatment, the total clinical effect, such as the plasma glucose level, the dosage of insulin, the rate of hypoglycemia, the grades of the incision healing, were observed and analyzed to evaluate the differences between the two groups. Results The time of plasma glucose for achieving the target, the dosage of insulin, and rate of hypoglycemia were shorter in the CSI group (group A) than the MSI group (group B). There were no significance differences in the grades of incision healing between the two groups. Conclusion The application of CSI in the perioperative diabetic patients can bring better glucose control, shorten the time of plasma glucose for achieving the target and the preoperative preparation time. And it also can decrease the rate of hypoglycemia. Thus the CSI is an effective way to control the plasma glucose level of the perioperative diabetic patients.
